-
2025-523938-10-00
5
2026-05-05
Diabetic Macular Edema (DME)
-
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
-
2025-523557-33-00
4
2026-04-20
Moderate-to-Severe Hidradenitis Suppurativa
-
2024-513174-22-00
4
2026-04-14
Atrophic Age-related Macular Degeneration (AMD)
-
2025-522231-34-00
5
2026-03-31
Diabetic Macular Edema
-
2025-522578-35-00
4
2026-03-30
Atopic Dermatitis
-
2025-521416-19-00
4
2026-03-12
Recurrence of Clostridioides difficile Infection
-
2025-522232-13-00
4
2026-03-06
Sepsis-associated acute kidney injury (AKI)
-
2025-521670-34-00
5
2026-03-04
Acute coronary syndrome (ST-elevation myocardial infarction [STEMI] or
-
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
-
2025-521636-10-00
4
2026-02-04
Progressive Forms of Multiple Sclerosis (PMS)
-
2025-522333-61-00
4
2026-01-23
Hidradenitis suppurativa
-
2024-519820-26-00
4
2026-01-22
Hallucinations and Delusions Associated with Alzheimer’s Disease Psych
-
2025-521917-24-00
5
2026-01-21
Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carci
-
2024-512298-28-00
11
2025-12-18
Neovascular age-related macular degeneration
-
2025-521349-25-00
5
2025-12-09
Macular neovascularization secondary to age-related macular degenerati
-
2024-519712-13-00
5
2025-12-08
Hypertriglyceridemia (HTG)
-
2024-512577-27-00
5
2025-12-02
Chronic kidney disease in paediatric patients
-
2024-517614-14-00
4
2025-11-28
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
-
2025-522347-18-00
4
2025-11-26
Major Depressive Disorder (MDD), with or without Anxious Distress
-
2024-520384-14-00
4
2025-11-20
Centre-involved diabetic macular edema
-
2024-518156-24-00
5
2025-11-10
Atopic Dermatitis
-
2024-518206-40-00
5
2025-11-03
Severe hypertriglyceridemia (SHTG)
-
2024-518365-10-00
5
2025-10-28
Previously Untreated Advanced or Metastatic Non-Squamous Non−Small Cel